Oppenheimer Raises Regeneron Pharmaceuticals' Price Target to $1,125, Maintains 'Hold' Rating

Gelonghui December 27 | Oppenheimer: Raised the target price for Regeneron Pharmaceuticals, Inc. from $1050 to $1125, maintaining a "Hold" rating.